Amy C. Rhee, MS

Placeholder Person Graphic
Amgen, Inc.
Senior Manager, Regulatory Affairs CMC
Amy C. Rhee, MS, is a Senior Manager, Regulatory Affairs CMC at Amgen, Inc. She received her BA from Washington University at St. Louis and a MS in RNA molecular biology from Case Western Reserve University. Her technical knowledge, ranging from molecular biology to downstream purification to drug product fill and finish, prepared her for her current role as a global product lead in RA CMC lifecycle management and global regulatory strategy development. Prior to working in regulatory, she held various positions in academic labs, in drug substance process development at Fraunhofer Center for Molecular Biotechnology, and in drug product process development at Amgen.

Related Articles

Rapid Filter or Resin Change Strategies for Biomanufacturing
Technical
Rapid Filter or Resin Change Strategies for Biomanufacturing

Pandemic-related supply chain shortages have placed constraints on the supply of essential filters and chromatography resins. An agile regulatory pathway to implement alternative filters and resins into manufacturing is necessary to ensure the continued supply of approved biologics. To allow this in the US and potentially globally, the regulatory strategy proposed in this article is to provide...

Regulatory Landscape for Raw Materials: CMC Considerations
Features
Regulatory Landscape for Raw Materials: CMC Considerations

A reliable supply of raw materials is critical to maintain a robust supply chain to serve patients globally. With shortages, regulatory complexity is compounded due to differences in submission and data requirements from various regulatory agencies. Therefore, there is an increasing need to implement a harmonized regulatory infrastructure that is both flexible and predictable to provide more...